Correction of Hyperbilirubinemia in Gunn Rats by Surgical Delivery of Low Doses of Helper-Dependent Adenoviral Vectors

作者: Françoise Schmitt , Nunzia Pastore , Cecilia Abarrategui-Pontes , Maude Flageul , Anne Myara

DOI: 10.1089/HGTB.2013.236

关键词: Transduction (genetics)Gunn ratPharmacologyBiologyLow doseTransgeneChronic toxicityImmunologyAcute toxicityHelper dependent adenoviralGenetic enhancement

摘要: Abstract Helper-dependent adenoviral (HDAd) vectors are attractive for liver-directed gene therapy because they can drive sustained high levels of transgene expression without chronic toxicity. However, vector doses required to achieve efficient hepatic transduction by systemic delivery a nonlinear dose response. Unfortunately, such result in dissemination and dose-dependent acute toxicity with potential lethal consequences. We have previously shown nonhuman primates that HDAd surgically isolated livers resulted significantly higher reduced compared intravenous multiyear expression. Encouraged these data, we now employed surgical method the Gunn rat, an animal model Crigler–Najjar syndrome. After into liver, show phenotypic correction at low clinically relevant dos...

参考文章(31)
Boudewijn van Etten, Flavia Brunstein, Marc G. A. van IJken, Andreas W. K. S. Marinelli, Cornelis Verhoef, Joost R. M. van der Sijp, Gunther Guetens, Gert de Boeck, Ernst A. de Bruijn, Johannes H. W. de Wilt, Alexander M. M. Eggermont, Isolated hypoxic hepatic perfusion with orthograde or retrograde flow in patients with irresectable liver metastases using percutaneous balloon catheter techniques: a phase I and II study. Annals of Surgical Oncology. ,vol. 11, pp. 598- 605 ,(2004) , 10.1245/ASO.2004.09.021
Frederick A. Nunes, Emma E. Furth, James M. Wilson, Steven E. Raper, Gene transfer into the liver of nonhuman primates with E1-deleted recombinant adenoviral vectors: safety of readministration. Human Gene Therapy. ,vol. 10, pp. 2515- 2526 ,(1999) , 10.1089/10430349950016852
Nicola Brunetti-Pierri, Donna J. Palmer, Viraj Mane, Milton Finegold, Arthur L. Beaudet, Philip Ng, Increased Hepatic Transduction with Reduced Systemic Dissemination and Proinflammatory Cytokines Following Hydrodynamic Injection of Helper-Dependent Adenoviral Vectors Molecular Therapy. ,vol. 12, pp. 99- 106 ,(2005) , 10.1016/J.YMTHE.2005.03.001
Nicola Brunetti-Pierri, Thomas Ng, David Iannitti, William Cioffi, Gary Stapleton, Mark Law, John Breinholt, Donna Palmer, Nathan Grove, Karen Rice, Cassondra Bauer, Milton Finegold, Arthur Beaudet, Charles Mullins, Philip Ng, Transgene Expression up to 7 Years in Nonhuman Primates Following Hepatic Transduction with Helper-Dependent Adenoviral Vectors Human Gene Therapy. ,vol. 24, pp. 761- 765 ,(2013) , 10.1089/HUM.2013.071
T H Nguyen, D Aubert, M Bellodi-Privato, M Flageul, V Pichard, Z Jaidane-Abdelghani, A Myara, N Ferry, Critical assessment of lifelong phenotype correction in hyperbilirubinemic Gunn rats after retroviral mediated gene transfer Gene Therapy. ,vol. 14, pp. 1270- 1277 ,(2007) , 10.1038/SJ.GT.3302993
Núria Morral, Wanda K. O'Neal, Karen Rice, M. Michelle Leland, Pedro A. Piedra, Estuardo Aguilar-Córdova, K. Dee Carey, Arthur L. Beaudet, Claire Langston, Lethal toxicity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboons. Human Gene Therapy. ,vol. 13, pp. 143- 154 ,(2002) , 10.1089/10430340152712692
Ira J. Fox, Jayanta Roy Chowdhury, Stuart S. Kaufman, Timothy C. Goertzen, Namita Roy Chowdhury, Phyllis I. Warkentin, Kenneth Dorko, Bernhard V. Sauter, Stephen C. Strom, Treatment of the Crigler–Najjar Syndrome Type I with Hepatocyte Transplantation The New England Journal of Medicine. ,vol. 338, pp. 1422- 1426 ,(1998) , 10.1056/NEJM199805143382004
Kevin A. Strauss, Donna L. Robinson, Hendrik J. Vreman, Erik G. Puffenberger, Graham Hart, D. Holmes Morton, Management of hyperbilirubinemia and prevention of kernicterus in 20 patients with Crigler-Najjar disease. European Journal of Pediatrics. ,vol. 165, pp. 306- 319 ,(2006) , 10.1007/S00431-005-0055-2